Thousands except per share amounts
Total
Common Stock Stock-
Additional Retained holders'
Shares Amount Capital Earnings Equity
Balance at January 25, 2007 37,406 18,703 250,113 546,741 815,557
Cumulative effect of
accounting change (Note 2) (526) (526)
Net income 96,201 96,201
Dividends ($.56 per share) (21,183) (21,183)
Stock contributions to
employee retirement plan 278 139 13,296 13,435
Stock awards, net of
forfeitures 144 72 (5,556) (5,484)
Stock-based compensation
expense 19,926 19,926
Stock options exercised 850 425 19,268 19,693
Tax benefit related to stock
awards and stock options, net 10,094 10,094
Repurchase of common stock (2,474) (1,237) (18,756) (99,795) (119,788)
Balance at January 31, 2008 36,204 $18,102 $288,385 $521,438 $827,925
Net income 51,036 51,036
Dividends ($.28 per share) (10,127) (10,127)
Stock contributions to
employee retirement plan 305 153 13,631 13,784
Stock awards, net of
forfeitures 263 131 (2,374) (2,243)
Stock-based compensation
expense 7,137 7,137
Stock options exercised 137 68 3,512 3,580
Tax benefit related to stock<
'/>"/>
| SOURCE Longs Drug Stores Corporation Copyright©2008 PR Newswire. All rights reserved |